Rhode Island 2025 Regular Session

Rhode Island House Bill H5116

Introduced
1/22/25  

Caption

Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.

Companion Bills

No companion bills found.

Similar Bills

NJ A1646

Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

ME LD697

An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing

VA HB1724

Prescription Drug Affordability Board; established, drug cost affordability review, report.

TX HB25

Relating to wholesale importation of prescription drugs in this state; authorizing a fee.

RI H5632

Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.

WV HB2831

Creating the Prescription Drug Affordability Board

GA HB931

Health; control high costs of prescription drugs; establish framework

KS SB212

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.